Drug delivery devices: Here is West’s plan for success

Share

West SelfDose SmartDose drug delivery devices

The SmartDose platform (left) and the SelfDose patient-controlled injector (right) [Images courtesy of West]

West Pharmaceutical Services is betting that an embrace of human factors engineering and experiential design will allow its drug delivery devices such as its SmartDose and SelfDose to stand apart from the crowd.

People are more likely to take their medications properly if a device is easy to use, Eric Resnick, vice president and chief technology officer at West (Exton, Pa.), explained this week at MD&M East in New York.

That’s a strong value argument for health providers because medication adherence is an important part of efficiently and effectively managing patient populations – something that public and private health insurers alike are increasingly requiring.

“It isn’t just about the drug and the container and the device. It’s integrating all those but then thinking patient, caregiver, family … the ecosystem behind it,” Resnick said.

Get the full story on our sister site, Drug Delivery Business.

Join us in Southern California this December for DeviceTalks West on 12/11-12/12

textadimage We've attracted a diverse group of thought leaders from some of the Golden State's best medtech companies — including Bigfoot Biomedical, BD, Alphabet's Verily, Integer, Medtronic Neurovascular, Medtronic Diabetes, Smith & Nephew and many more for DeviceTalks West.

Check out our web site for latest news on speakers, agenda and event information.


Get your tickets today! »

Speak Your Mind

*